Form 4 for PCVX Vaxcyte, Inc.
Accepted 2026-01-16 00:00:00 ET · period of report 2026-01-14 · accession 0001258693-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-16 | 2026-01-14 | PCVX | PICKERING GRANT | CEO, Dir | G - Gift | $0.00 | -100.0K | 400.9K | -20% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-14 | G | D | 100,000 | $0.00 | 400,908 | D | — | — | (F1) The reported transaction involves the Reporting Person's transfer of shares to an irrevocable trust for estate planning purposes. The Reporting Person no longer has a pecuniary interest in the shares and therefore disclaims beneficial ownership. |